1. STI Testing Rate
|
Proportion of clients tested for STIs (CT, NG, TV, syphilis and HIV) during the reporting period
|
2. STI Testing Coverage
|
Proportion of current clients tested for STIs at least once in a 12-month period
|
3. STI test positivity
|
Proportion of clients with at least one positive STI test in a 12-month period
|
4. Completeness of STI Testing
|
Proportion of clients with a positive CT and/or NG and/or TV result also tested for syphilis and HIV within 30 days of date of initial specimen collection
|
5. STI Treatment Interval
|
Time (days) from date of positive STI (CT, NG, TV) test to date of treatment
|
6. STI Retesting Rate
|
Proportion of clients retested at approximately three months (60 to 120 days) following treatment for an initial positive STI (CT/NG/TV) result
|
7. STI Repeat Positivity Rate
|
Proportion of clients retested at approximately three months (60 to 120 days) after treatment for an initial positive CT/NG result and who retested positive for CT/NG at this time
|
8. Hepatitis B Virus (HBV) Testing Rate
|
Proportion of clients receiving an HBV test. Among those testing negative, the proportion who subsequently received one or more dose of vaccination.
|
9. Hepatitis C (HCV) Testing Rate
|
Proportion of clients receiving an HCV antibody test and among those testing positive, the proportion then tested for RNA or viral load.
|
10. HCV Treatment Uptake
|
Proportion of HCV RNA positive clients prescribed Direct Acting Antiviral (DAA) treatment
|
11. HCV Sustained Virological Response
|
Proportion of clients who, after having been prescribed DAA treatment, achieve an undetectable viral load
|
12. HPV Screening Rate
|
Proportion of female clients screened for human papillomavirus in line with national guidelines
|